NDC 68788-8203-08 - Acyclovir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-8203
- Requested NDC
- 68788-8203-08
- Package NDCs from labels
- 68788-8203-2, 68788-8203-3, 68788-8203-8, 68788-8203-4, 68788-8203-5, 68788-8203-1, 68788-8203-08
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Effective date
- 2026-01-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acyclovir Tablets, USP | Preferred Pharmaceuticals Inc. | 2026-01-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-8203-1 | Acyclovir | 100 in 1 BOTTLE | TABLET | 100 | 6 | |
| 68788-8203-2 | Acyclovir | 21 in 1 BOTTLE | TABLET | 21 | 6 | |
| 68788-8203-3 | Acyclovir | 30 in 1 BOTTLE | TABLET | 30 | 6 | |
| 68788-8203-4 | Acyclovir | 40 in 1 BOTTLE | TABLET | 40 | 6 | |
| 68788-8203-5 | Acyclovir | 50 in 1 BOTTLE | TABLET | 50 | 6 | |
| 68788-8203-8 | Acyclovir | 35 in 1 BOTTLE | TABLET | 35 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-8203 | ACYCLOVIR TABLET [PREFERRED PHARMACEUTICALS INC.] | 5 | Current NDC, Legacy NDC, 6 package rows | 20250101_b1033fda-8242-4006-b1cd-23474d70671f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-8203-1 | EA - Each | 68788-8203 | b06ee593-5f97-47aa-a659-9211520bc357 | 1 | 2022-07-06 |
| 68788-8203-2 | EA - Each | 68788-8203 | 7bd14f5f-f223-4e95-96e7-51fa707416b2 | 1 | 2022-07-06 |
| 68788-8203-3 | EA - Each | 68788-8203 | 34aa2bb0-dff4-4ab3-9f07-9950111c12ee | 1 | 2022-07-06 |
| 68788-8203-4 | EA - Each | 68788-8203 | 8b554cc8-9075-47c9-9774-23f614948f6f | 1 | 2022-07-06 |
| 68788-8203-5 | EA - Each | 68788-8203 | 5a7b6fd2-4f14-42d8-bb5b-d204de588384 | 1 | 2022-07-06 |
| 68788-8203-8 | EA - Each | 68788-8203 | d1b9338f-59f0-4ae6-8dba-222fcdd83410 | 1 | 2022-07-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ACYCLOVIR | ACYCLOVIR | REMEDYREPACK INC. | c1744e01-0e40-4851-8ffc-c3bf29dd7c2b | 2026-08-31 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals, Inc. | 5176c7f9-9076-4797-e054-00144ff8d46c | 2026-08-27 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | NuCare Pharmaceuticals,Inc. | e5e99a6b-79a6-7fdb-e053-2a95a90a8563 | 2026-08-26 | Warnings, Adverse reactions | ANDA209366 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | PD-Rx Pharmaceuticals, Inc. | 58dc1402-6098-9cb3-e063-6294a90a062b | 2026-08-19 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| acyclovir | ACYCLOVIR | Northwind Health Company, LLC | 50c58161-3944-7367-e063-6394a90a6286 | 2026-08-19 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Cardinal Health 107, LLC | 4cc7d67f-35fa-4238-a581-4810645083cf | 2026-08-13 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | c | 59007780-d736-4195-a204-7f85a709ed46 | 2026-08-12 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 0de2f5c7-9e75-4bdf-9c28-e026cc6694b4 | 2026-07-24 | Warnings, Adverse reactions | 197313 197311 X4HES1O11F |
| acyclovir | ACYCLOVIR | PD-Rx Pharmaceuticals, Inc. | 86c43bdf-c5bf-47cd-8dfd-811263825878 | 2026-07-24 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 6d0e492e-5359-49e8-812d-8c8e2e5d42f8 | 2026-07-24 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 736679be-469e-4bdb-8e15-b10751c3dd60 | 2026-07-24 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 38547daa-7d2f-4a7b-84d3-6e164984f958 | 2026-07-17 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Major Pharmaceuticals | 9b254eed-8ea1-469b-bf27-f5670cd99e8d | 2026-07-14 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | ATLANTIC BIOLOGICALS CORP. | da5a809c-6ddc-4609-9a34-ccb3d2d43976 | 2026-07-10 | Warnings, Adverse reactions | X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 85332671-0e3a-4445-a337-e1266886b9cf | 2026-07-08 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 499c6a98-0614-4ded-8526-909942bae8a4 | 2026-06-26 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 37a51d9c-1f39-4065-8c7d-6528ac6de91c | 2026-06-23 | Warnings, Adverse reactions | ANDA209366 197313 X4HES1O11F |
| ACYCLOVIR | ACYCLOVIR | Alembic Pharmaceuticals Inc. | 878615c2-09ea-44ce-8c30-7a7f16acb20c | 2026-06-18 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | Bryant Ranch Prepack | db35fce0-d7a3-4589-ba60-d78cdb1119cb | 2026-06-18 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Redpharm Drug | 53cbca4d-3ddc-b11e-e063-6394a90a04fa | 2026-06-09 | Warnings, Adverse reactions | 197313 X4HES1O11F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.